INS and Sepsis: In a study by Van den Berghe and coworkers, in patients who received aggressive insulin therapy to maintain serum glucose ≤110 mg/dL, cardiac surgical mortality was only reduced in those patients receiving more than 3 days of ICU care and in those with multiorgan failure and sepsis [68].